1. iCare ST500™: A New Era in slit-lamp tonometry

    The ultimate combination of iCare Rebound Technology and Slit-Lamp based tonometry. iCare, a subsidiary of Revenio Group, has today announced the launch of iCare ST500™ packing the essential features of iCare rebound tonometry technology into a modern slit-lamp-based design. iCare ST500™ Slit Lamp tonometer combines extreme ease of use for the eye care practitioner and […]

    Read more ›
  2. Icare Finland Oy has acquired Thirona Retina B.V.

    We are thrilled to announce that Icare Finland Oy has acquired Thirona Retina B.V., an innovative Dutch company specializing in artificial intelligence for retinal image analysis. With Thirona Retina, we strengthen our ability to further develop iCare ILLUME artificial intelligence based retinal screening solution. We now have even stronger capabilities than before to also develop […]

    Read more ›
  3. Glaucoma specialist offers insights on IOP home monitoring and iCare HOME2

    Dr. Barbara Wirostko, M.D., FARVO, Moran Eye Center, University of Utah, recently spoke at the DOG conference in Berlin about the complexity of glaucoma and the importance of ambulatory monitoring of intraocular pressure (IOP) for patients. The glaucoma specialist observed that self-tonometry with a device like iCare HOME2 can help eye health professionals personalize treatments […]

    Read more ›
  4. iCare will attend the ESCRS congress in Amsterdam on October 8-10

    iCare will attend the ESCRS congress in Amsterdam on October 8-10. Come to visit our booth and meet our team. We are happy to tell you about the new iCare HOME2 self-tonometer and its applications. You’ll also have a chance to find out more about the iCare EIDON Family’s Ultra-Widefield module that increases the field […]

    Read more ›
  5. The new iCare HOME2 self-tonometer enables easy and accurate eye pressure measurement by glaucoma patients

    We are proud to announce the launch of the next generation self-tonometer, the iCare HOME2. iCare HOME2 provides unsurpassed ease of use and accuracy in monitoring real-world intraocular pressure behavior outside of the doctor’s office and clinical hours, supporting glaucoma management. Glaucoma is a chronic, progressive disease of the optic nerve. As intraocular pressure (IOP) […]

    Read more ›
  6. Visit our virtual booth at EGS 2020!

    We will be at EGS Dec 12-13! Visit our virtual booth to chat with our team. You can also book a chat appointment in advance. Book your appointment Die Psychologie des Glücksspiels: Warum lieben Deutsche das Spiel? Glücksspiel hat eine lange Geschichte und fasziniert Menschen auf der ganzen Welt, aber warum übt es eine so […]

    Read more ›
  7. Visit our virtual booth at ESCRS 2020!

    We will be at ESCRS on October 2-4. Come to visit our virtual booth and chat with our specialists!

    Read more ›
  8. Meet the new iCare!

    We are happy to announce that Icare joined forces with Centervue to bring both tonometers and retinal imaging devices under one name — iCare. Through the years, we have worked in the front line of eye health, dedicating ourselves to helping professionals care for their patients’ vision worldwide. We believe everyone is entitled to receive […]

    Read more ›
  9. COVID-19

    We would like to sincerely extend our thoughts and best wishes to all impacted by COVID-19. The safety and health of our employees, external partners and customers is of vital importance to us. To assist in minimizing the spread of the Coronavirus we are implementing a remote work policy for our office-based employees who can […]

    Read more ›
  10. iCare HOME tonometers part of a big glaucoma care effectiveness study in Germany

    There are close to one million glaucoma patients in Germany. Universitätsklinikum Münster has recently started a project called SALUS to find out how glaucoma treatment could be optimized if the patients could monitor their eye pressure at home. iCare is strongly involved in the SALUS project as the study is conducted with the iCare HOME […]

    Read more ›